Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,755.20
(
-1.56%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
108.82
(
2.10%
)
Bitcoin
70,960.00
(
-0.37%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: exwannabe post# 59840

Monday, 03/03/2008 6:03:33 PM

Monday, March 03, 2008 6:03:33 PM

Post# of 257257
>Just like those two onc. biotechs saying their drug is approved for commercial use in Switzerland when they really have something like an IND and an import/export license. Those 2 PR's were flagrant lies.<

The two cases (NWBO and Vaccinogen) were almost certainly related. Vaccinogen noticed that NWBO got away with a scam pump job that produced nary a peep from the SEC. I expect to see more of these PR’s about Swiss “approvals” if nothing is done to stop them.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now